Clinical Chats: a Podcast for Sexual and Reproductive Health Professionals · Clinical Training Center for Sexual and Reproductive Health

Harm Reduction and Sexual and Reproductive Healthcare for Women

October 20, 2023·40 min·1 clip

Harm reduction recognizes that drug policy itself can have harms.

The conversation is direct and practical. It places harm reduction inside sexual and reproductive healthcare, where clinicians need a usable framework for talking about substance use without losing sight of patient goals. Dr. Turplin defines harm reduction as both a philosophy and a practice. He describes it as a way of working with people that meets them where they are rather than forcing every encounter into an abstinence-first script. The episode then asks why the approach matters for Title X clinicians and related staff. The answer is rooted in everyday care, because screening, counseling, and follow-up become more useful when they are shaped by what a patient actually uses, what they are worried about, and what they want next. Pregnancy comes up early. That section focuses on patients who want pregnancy, are pregnant, or test positive while still using substances, and it makes the case for separating substance use disorder from use or misuse before deciding what comes next. Assessment is central. The discussion points to validated screening or a careful conversation about recent use, the type of substance, and whether the patient meets criteria for a disorder. That distinction changes the plan. If a person has a substance use disorder, treatment is appropriate, but if they do not, forcing treatment can be unhelpful and even harmful. The episode also notes the scarcity of addiction treatment. That scarcity matters clinically and ethically, because putting resources in the wrong place can leave people with actual disorders waiting longer than they should. Cannabis is used as a concrete example. The clinician is encouraged to ask what the patient likes about it, what they worry about, what they hope to change, and whether an intermediate goal would be more realistic than an immediate quit date. Follow-up is treated as part of care, not an optional add-on. Dr. Turplin describes checking back in, adjusting the plan, and building toward goals over time instead of treating the first conversation as the last. The episode broadens again at the end. It argues for including people affected by care decisions in those decisions, inside the clinic and beyond it, because the work is about more than wellness or drugs; it is about the kind of healthcare system people are building together.

As heard by us

A careful clinical discussion of harm reduction, pregnancy, and matching care to the patient’s actual needs.

The episode treats harm reduction as both a philosophy and a clinical practice for sexual and reproductive healthcare professionals, and it stays focused on what clinicians should do. Dr.

Read the full review in PlayNext →

Why you'd press play

You want a practical, clinician-facing way to talk substance use, pregnancy, and care without moralizing.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Clinical Chats: a Podcast for Sexual and Reproductive Health Professionals